Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C et al (2022) Gastric cancer, Version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 20(2):167–92

Article  CAS  Google Scholar 

Drubay V, Nuytens F, Renaud F, Adenis A, Eveno C, Piessen G (2022) Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management. World J Gastrointest Oncol 14(8):1406–1428

Article  PubMed  PubMed Central  Google Scholar 

Johnston FM, Beckman M (2019) Updates on management of gastric cancer. Curr Oncol Rep 21(8):67

Article  PubMed  Google Scholar 

Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G et al (2022) Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 33(10):1005–1020

Article  PubMed  CAS  Google Scholar 

Shen J, Ma X, Yang J, Zhang JP (2019) Digestive tract reconstruction options after laparoscopic gastrectomy for gastric cancer. World J Gastrointest Oncol 12(1):21–36

Article  Google Scholar 

Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T et al (2022) The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: a population-based modelling study. EClinicalMedicine 47:101404

Article  PubMed  PubMed Central  Google Scholar 

Sexton RE, Hallak MN Al, Uddin MdH, Diab M, Azmi AS (2020) Gastric cancer heterogeneity and clinical outcomes. Technol Cancer Res Treat. 19:153303382093547

Article  Google Scholar 

Zhang C, Liu R, Zhang WH, Chen XZ, Liu K, Yang K et al (2021) Difference between signet ring cell gastric cancers and non-signet ring cell gastric cancers: a systematic review and meta-analysis. Front Oncol 11:618477

Zaafouri H, Jouini R, Khedhiri N, Khanchel F, Cherif M, Mesbahi M et al (2022) Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis—a cohort study of 123 patients from a non-endemic country. World J Surg Oncol 20(1):238

Article  PubMed  PubMed Central  Google Scholar 

Tang YH, Ren LL, Mao T (2023) Update on diagnosis and treatment of early signet-ring cell gastric carcinoma: a literature review. World J Gastrointest Endosc 15(4):240–247

Article  PubMed  PubMed Central  Google Scholar 

Pernot S (2015) Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol 21(40):11428

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xu Z, Jin Y, Fang X (2018) Advances in the research of gastric signet ring cell carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi 21(10):1196–1200

PubMed  Google Scholar 

Laurén P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64(1):31–49

Article  PubMed  Google Scholar 

Berlth F, Bollschweiler E, Drebber U, Hoelscher AH, Moenig S (2014) Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. World J Gastroenterol 20(19):5679–5684

Article  PubMed  PubMed Central  Google Scholar 

Zhao B, Lv W, Zhang J, Zhang J, Huang B, Lin J (2020) Different prognostic significance of signet ring cell histology for early and advanced gastric cancer patients: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 14(6):499–509

Article  PubMed  CAS  Google Scholar 

Mariette C, Carneiro F, Grabsch HI, van der Post RS, Allum W, de Manzoni G (2019) Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer 22(1):1–9

Article  PubMed  CAS  Google Scholar 

Zhao X, Cai A, Xi H, Song Y, Wang Y, Li H et al (2017) Predictive factors for lymph node metastasis in early gastric cancer with signet ring cell histology: a meta-analysis. ANZ J Surg 87(12):981–986

Article  PubMed  Google Scholar 

Kao YC, Fang WL, Wang RF, Li AFY, Yang MH, Wu CW et al (2019) Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer. Gastric Cancer 22(2):255–263

Article  PubMed  CAS  Google Scholar 

Wang Z, Zhang X, Hu J, Zeng W, Zhou Z (2015) Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology. J Visc Surg 152(6):357–361

Article  PubMed  CAS  Google Scholar 

Yao K, Anagnostopoulos G, Ragunath K (2009) Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy 41(05):462–467

Article  PubMed  CAS  Google Scholar 

Phalanusitthepha C, Grimes KL, Ikeda H, Sato H, Sato C, Hokierti C et al (2015) Endoscopic features of early-stage signet-ring-cell carcinoma of the stomach. World J Gastrointest Endosc 7(7):741

Article  PubMed  PubMed Central  Google Scholar 

Machlowska J, Pucułek M, Sitarz M, Terlecki P, Maciejewski R, Sitarz R (2019) State of the art for gastric signet ring cell carcinoma: from classification, prognosis, and genomic characteristics to specified treatments. Cancer Manag Res 11:2151–2161

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kang SH, Kim JS, Moon HS, Lee ES, Kim SH, Sung JK et al (2017) Signet ring cell carcinoma of early gastric cancer, is endoscopic treatment really risky? Medicine 96(33):e7532

Article  PubMed  PubMed Central  Google Scholar 

Lee JH, Choi IJ, Kook MC, Nam BH, Kim YW, Ryu KW (2010) Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology. Br J Surg 97(5):732–736

Article  PubMed  CAS  Google Scholar 

Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L (1999) Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian gastrointestinal tumor study group. Ann Surg 230(2):170–8

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim JH, Lee YC, Kim H, Song KH, Lee SK, Cheon JH et al (2009) Endoscopic resection for undifferentiated early gastric cancer. Gastrointest Endosc 69(4):e1-9

Article  PubMed  Google Scholar 

Bang CS, Park JM, Baik GH, Park JJ, Joo MK, Jang JY et al (2017) Therapeutic outcomes of endoscopic resection of early gastric cancer with undifferentiated-type histology: a Korean ESD Registry Database Analysis. Clin Endosc 50(6):569–577

Article  PubMed  PubMed Central  Google Scholar 

Robb WB, Messager M, Gronnier C, Tessier W, Hec F, Piessen G et al (2015) High-grade toxicity to neoadjuvant treatment for upper gastrointestinal carcinomas: what is the impact on perioperative and oncologic outcomes? Ann Surg Oncol 22(11):3632–3639

Article  PubMed  Google Scholar 

Heger U, Blank S, Wiecha C, Langer R, Weichert W, Lordick F et al (2014) Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach? Ann Surg Oncol 21(5):1739–1748

Article  PubMed  Google Scholar 

Kim S, Fiteni F, Paget-Bailly S, Ghiringhelli F, Lakkis Z, Jary M et al (2015) The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomas. J Hematol Oncol 8(1):52

Article  PubMed  PubMed Central  Google Scholar 

Chen L, Shi Y, Yuan J, Wu Q, Han Y, Qin R et al (2014) Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients. Med Oncol 31(9):159

Article  PubMed  Google Scholar 

Cunningham S, Kamangar F, Kim M, Hammoud S, Haque R, Maitra A et al (2005) Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg 9(5):718–725

Article  PubMed  Google Scholar 

Lu M, Yang Z, Feng Q, Yu M, Zhang Y, Mao C et al (2016) The characteristics and prognostic value of signet ring cell histology in gastric cancer. Medicine 95(27):e4052

Article  PubMed  PubMed Central  Google Scholar 

Lemoine N, Adenis A, Bouche O, Duhamel A, Heurgue A, Leteurtre E et al (2016) Signet ring cells and efficacy of first-line chemotherapy in advanced gastric or oesogastric junction adenocarcinoma. Anticancer Res 36(10):5543–5550

Article  PubMed  CAS  Google Scholar 

Pernot S, Mitry E, Samalin E, Dahan L, Dalban C, Ychou M et al (2014) Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort. Gastric Cancer 17(2):341–347

Article  PubMed  CAS  Google Scholar 

Pernot S, Dubreuil O, Tougeron D, Soudan D, Bachet JB, Lepère C et al (2015) Docetaxel, 5FU, oxaliplatin (TEFOX) in 1st line treatment of signet ring cell and/or poorly differentiated gastric adenocarcinoma: a retrospective study of AGEO. J Clin Oncol 33(15_suppl):e15048

Article  Google Scholar 

Turgeon MK, Gamboa AC, Rupji M, Lee RM, Switchenko JM, El-Rayes BF et al (2021) Should signet ring cell histology alter the treatment approach for clinical stage I gastric cancer? Ann Surg Oncol 28(1):97–105

Article  PubMed  Google Scholar 

Arer IM, Yabanoglu H, Akdur A, Akkapulu N, Kus M (2017) Total versus subtotal gastrectomy for signet ring cell carcinoma of the sto